Patent Assignment
Reel/Frame 054344/0510
Security Interest
Recorded: 2020-11-06
Pages: 23
Assignor
NOVOCURE GMBH
Executed: 2020-11-06
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
IL1-1145/54/63, P.O. BOX 6026, CHICAGO, ILLINOIS, 60680-6026
Covered Properties
(146)
Method and Apparatus for Destroying Dividing Cells
Apparatus for Destroying Dividing Cells
Apparatus and Method for Treating a Tumor or the Like
Method and Apparatus for Destroying Dividing Cells
Apparatus for Treating a Tumor or the Like and Articles Incorporating the Apparatus for Treatment of the Tumor
Apparatus and Method for Optimizing Tumor Treatment Efficiency by Electric Fields
Treating a Tumor or the Like with an Electric Field That Is Focused at a Target Region
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with an Electric Field
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating a Tumor or the Like with Electric Fields at Different Orientations
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Treating a Tumor or the Like with Electric Fields at Different Orientations
Apparatus and Method for Preventing the Spread of Cancerous Metastases and for Elimination of Metastases
Hat for Treating a Tumor or the Like
Probe for Treating a Tumor or the Like
Article of Clothing for Treating a Tumor or the Like
Apparatus for Selectively Destroying Dividing Cells
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Composite Electrode
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Bacteria with Electric Fields
Treating Parasites with Electric Fields
Method and Apparatus for Destroying Dividing Cells
Patent:
43,618 →
Application:
12/199,498 →
Electrodes for Applying an Electric Field in-Vivo Over an Extended Period of Time
Optimizing Characteristics of an Electric Field to Increase the Field's Effect on Proliferating Cells
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens
Probe for Treating a Tumor or the Like
Treating Bacteria with Electric Fields
Treating a Tumor or the Like with Electric Fields at Different Frequencies
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Treating Cancer Using Electromagnetic Fields in Combination with Photodynamic Therapy
Composite Electrode
Optimizing Treatment Using Ttfields by Changing the Frequency During the Course of Long Term Tumor Treatment
Treating Bacteria with Electric Fields
Treating Bacteria with Electric Fields
High Voltage, High Efficiency Sine Wave Generator with Pre-Set Frequency and Adjustable Amplitude
TTField Treatment with Optimization of Electrode Positions on the Head Based on MRI-Based Conductivity Measurements
Reducing Motility of Cancer Cells Using Tumor Treating Fields (TTFields)
Optimizing Treatment Using TTfields by Changing the Frequency During the Course of Long Term Tumor Treatment
Arrays for Longitudinal Delivery of TTFields to a Body
Arrays for Longitudinal Delivery of TTFields to a Body
Application:
15/636,736 →
Publication:
US 2018/0001075
Temperature Measurement in Arrays for Delivering TTFields
Treating Patients with TTFields with the Electrode Positions Optimized Using Deformable Templates
System for Viewing Cell Cultures under a Microscope Whilst Applying TTFields
Delivering Tumor Treating Fields (TTFields) to the Infratentorial Brain
TTField Treatment with Optimization of Electrode Positions on the Head Based on MRI-Based Conductivity Measurements
Treating Tumors with TTFields and an Aurora Kinase Inhibitor
TTField Treatment with Optimization of Electrode Positions Based on Low Frequency (<1MHZ) AC Conductivity Estimates Derived From Two MRI Images Having Different Repetition Times
Using Alternating Electric Fields to Increase Cell Membrane Permeability
Application:
16/502,255 →
Publication:
US 2020/0009376
Using Alternating Electric Fields to Increase Cell Membrane Permeability
Methods and Compositions for Treating Tumors with TTFields and Sorafenib
Inhibiting Viral Infection Using Alternating Electric Fields
Using Power Loss Density and Related Measures to Quantify the Dose of Tumor Treating Fields (TTFields)
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Treating Autoimmune Diseases Using an Alternating Electric Field to Reduce the Proliferation of T-Cells
Arrays for Longitudinal Delivery of TTFields to a Body
Treating Tumors Using TTFields Combined with ABT-751
Application:
16/593,081 →
Publication:
US 2020/0108031
Generating Tumor Treating Fields (TTFields) with High Uniformity throughout the Brain
Generating Tumor Treating Fields (TTFields) with High Uniformity throughout the Brain
Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields
Application:
16/661,889 →
Publication:
US 2020/0121728
Delivering Alternating Electric Fields (e.g., TTFields) to a Subject's Spinal Anatomy
Methods for Reducing Viability of Cancer Cells by Activation of the STING Pathway with TTFields
Application:
16/673,246 →
Publication:
US 2021/0069503
Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images
Application:
16/680,953 →
Publication:
US 2020/0146586
Arrays for Delivering Tumor Treating Fields (TTFields) with Selectively Addressable Sub-Elements
Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields)
Evaluating Quality of Segmentation of an Image into Different Types of Tissue for Planning Treatment Using Tumor Treating Fields (TTFields)
Methods of Treating Glioblastoma
Application:
16/764,248 →
Publication:
US 2020/0368525
Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
Application:
16/790,014 →
Publication:
US 2020/0179512
Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof
Application:
16/794,728 →
Publication:
US 2020/0269041
Determining a Frequency for TTFields Treatment Based on an Electrical Characteristic of Targeted Cancer Cells
Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays
Methods for Restoring Sensitivity to TTFields in TTFields-Resistant Cancer Cells with PTGER3 Inhibitors
Uploading Data from an Isolated System without Compromising Isolation
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Using Alternating Electric Fields to Increase Cell Membrane Permeability
Methods, Systems, and Apparatuses for Managing Transducer Array Placement
Applying Tumor Treating Fields (TTFields) Via Electrodes Embedded into Skull Implants
Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity
Delivering Tumor Treating Fields (TTFields) to the Neck
Optimizing Treatment Using TTFields by Changing the Frequency During the Course of Long Term Tumor Treatment
Display Screen or Portion Thereof with a Graphical User Interface
Patent:
934,892 →
Application:
29/689,979 →
Electrode Array
Patent:
961,091 →
Application:
29/715,151 →
Electrode Array
Patent:
959,673 →
Application:
29/715,153 →
Electrode Array
Patent:
960,375 →
Application:
29/719,357 →
Animal Cage
Patent:
1,058,055 →
Application:
29/725,292 →
Applying Tumor Treating Fields (TTFields) Via Electrodes Embedded into Skull Implants
Application:
62/880,893 →
Delivering Tumor Treating Fields (TTFields) to the Neck
Application:
62/893,876 →
Treating Gastric Cancer Using TTFields Combined with FOLFOX or the Individual Constituents Thereof
Application:
62/912,483 →
Conductive Gel Compositions and Methods of Production and Use Thereof
Application:
62/932,653 →
Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof
Application:
62/932,834 →
Methods, Systems, and Apparatuses for Optimizing Transducer Array Placement
Application:
62/942,595 →
Compositions and Methods of Altering the Electric Impedance to an Alternating Electric Field Title
Application:
62/946,793 →
Compositions and Methods of Altering the Electric Impedance to an Alternating Electric Field Title
Application:
62/946,798 →
Compositions and Methods for Imaging a Cell
Application:
62/946,803 →
Swivel Assembly for Actively Limiting Torsion of a Cable, and Systems and Methods of Using Same
Application:
62/951,588 →
Cage Assembly for Animal Test Subjects
Application:
62/951,599 →
Treatment Assembly for Providing Tumor Treating Fields to Animal Test Subjects
Application:
62/951,605 →
Methods of Normalizing Aberrant Glycolytic Metabolism in Cancer Cells
Application:
62/953,704 →
Perforated Hydrogel Configurations and Methods of Production and Use Thereof
Application:
62/955,563 →
Methods, Systems, and Apparatuses for Image Segmentation
Application:
62/955,644 →
Arrays for Delivering Tumor Treating Fields (TTFields) with Individually Accessible Electrode Elements and Temperature Sensors
Application:
62/955,664 →
High Voltage, High Efficiency Sine Wave Generator That Prevents Spikes During Amplitude Adjustments
Application:
62/955,673 →
Methods, Systems, and Apparatuses for Fast Approximation of Electric Field Distribution
Application:
62/955,678 →
Methods, Systems, and Apparatuses for Managing Temperatures Induced by Alternating Fields
Application:
62/955,747 →
Methods, Systems, and Apparatuses for Associating Dielectric Properties with a Patient Model
Application:
62/955,752 →
Perforated Hydrogel Configurations and Methods of Production and Use Thereof
Application:
62/956,916 →
Assemblies Containing Two Conductive Gel Compositions and Methods of Production and Use Thereof
Application:
62/964,275 →
High Voltage, High Efficiency Sine Wave Generator that Prevents Spikes During Amplitude Adjustments
Application:
62/981,875 →
Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
Application:
63/002,042 →
Methods, Systems, and Apparatuses for Assisted Transducer Array Placement
Application:
63/002,937 →
Assemblies Containing Two Conductive Gel Compositions and Methods of Production and Use Thereof
Application:
63/004,016 →
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Application:
63/015,099 →
Conductive Gel Compositions Comprising Bulk Electron Transport Agents and Methods of Production and Use Thereof
Application:
63/020,636 →
Compositions And Methods Of Applying Alternating Electric Fields To Pluripotent Stem Cells
Application:
63/022,162 →
Conductive Pad with Improved Air Flow and Methods of Production and Use Thereof
Application:
63/030,138 →
Implantable Arrays for Providing Tumor Treating Fields
Application:
63/033,511 →
Implantable Arrays for Providing Tumor Treating Fields
Application:
63/033,518 →
TTF Generated Proliferation of Cytotoxic T Cells to Create a Specific Pro-Inflammatory Response
Application:
63/041,211 →
Fabricating Organic Light Emitting Diodes (OLEDs) Using Tubulin
Application:
63/043,891 →
Genome Wide Expression and Anti-Proliferative Effects of TTFields Therapy on Pediatric and Adult Brain Tumors
Application:
63/045,378 →
Methods and Systems for Restoring NADH/NAD+ Redox Balance with TTFields
Application:
63/045,390 →
Methods and Systems for Increasing Butyrophilin 9 (Btnl9) Protein Expression with TTFields
Application:
63/045,980 →
Flexible Transducer Arrays with Polymer Insulating Layer for Applying Tumor Treating Fields (TTFields)
Application:
63/046,337 →
Conductive Pad Generating Tumor Treating Field and Methods of Production and Use Thereof
Application:
63/046,364 →
Methods And Systems For Guiding Transducer Array Placement
Application:
63/056,262 →
Compositions And Methods For Increasing Cancer Cell Sensitivity To Alternating Electric Fields
Application:
63/060,506 →
Conductive Pad with Improved Air Flow and Methods of Production and Use Thereof
Application:
63/061,316 →
Conductive Pad Incorporating a Conductive Fabric Material
Application:
63/061,419 →
Breathable Pad Generating Tumor Treating Field and Methods of Production and Use Thereof
Application:
63/068,213 →
Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier
Application:
63/071,748 →
Methods and Compositions for Treating Coronavirus
Application:
63/080,101 →
Methods and Compositions for Treating Coronavirus
Application:
63/083,456 →
Flexible Transducer Arrays with Polymer Insulating Layer for Applying Tumor Treating Fields (TTFields)
Application:
63/083,557 →
Varying the Metallization Area on Individual Electrode Elements in a Tumor Treating Fields (TTFields) System to Maximize Current without Overheating
Application:
63/083,590 →
Transducer Array Flexibility and Methods of Production and Use Thereof
Application:
63/085,476 →
Implantable Arrays for Providing Tumor Treating Fields
Application:
63/085,603 →
Implantable Arrays for Providing Tumor Treating Fields
Application:
63/085,658 →
Connector for Detachable Array
Application:
63/085,733 →
Methods and Systems for Transducer Array Placement and Skin Surface Condition Avoidance
Application:
63/085,905 →
Method and Apparatus for Delivering Tumor Treating Fields to a Torso
Application:
63/085,934 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jul 11, 2012
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 028527/0432 →
Release of Security Interest
Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →
Assignment of Assignor's Interest
Dec 18, 2014
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 034548/0231 →
Change of Name
Dec 29, 2014
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 034594/0061 →
Security Interest
Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
Release of Security Interest
Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
Security Interest
Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
Security Interest
May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
Assignment of Assignor's Interest
Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
Release of Security Interest
Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 045278/0825
Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
Omnibus Confirmation of Assignment Agreement
May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 50395/0398
Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
Release of Security Interest for Patent Security Agreement Filed at Reel/Frame 45278 0825
Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
Release of Security Interest
Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
Patent Security Agreement
May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →